RYNVX
Price
$176.09
Change
+$0.95 (+0.54%)
Updated
Oct 6 closing price
Net Assets
269.38M
RYVLX
Price
$712.96
Change
+$10.72 (+1.53%)
Updated
Oct 6 closing price
Net Assets
1.45B
Interact to see
Advertisement

RYNVX vs RYVLX

Header iconRYNVX vs RYVLX Comparison
Open Charts RYNVX vs RYVLXBanner chart's image
Rydex Nova I
Price$176.09
Change+$0.95 (+0.54%)
VolumeN/A
Net Assets269.38M
Rydex NASDAQ-100® 2x Strategy A
Price$712.96
Change+$10.72 (+1.53%)
VolumeN/A
Net Assets1.45B
RYNVX vs RYVLX Comparison Chart in %
View a ticker or compare two or three
VS
RYNVX vs. RYVLX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYNVX is a Buy and RYVLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.45B vs. RYNVX (269M). RYNVX pays higher dividends than RYVLX: RYNVX (0.56) vs RYVLX (0.00). RYNVX was incepted earlier than RYVLX: RYNVX (32 years) vs RYVLX (21 years). RYVLX (1.87) is less costly to investors than RYNVX (1.37). RYVLX is a more actively managed with annual turnover of: 383.00 vs. RYNVX (180.00). RYNVX (2500) and RYVLX (2500) have matching initial minimum investment requirements. RYVLX annual gain was more profitable for investors over the last year : 30.29 vs. RYNVX (22.07). RYVLX return over 5 years is better than : 140.31 vs. RYNVX (84.25).
RYNVXRYVLXRYNVX / RYVLX
Total Expense Ratio1.321.7476%
Annual Report Gross Expense Ratio1.371.8773%
Fund Existence32 years21 years-
Gain YTD18.83627.54868%
Front LoadN/A5%-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets269M1.45B19%
Annual Yield % from dividends0.560.00-
Returns for 1 year22.0730.2973%
Returns for 3 years88.55252.7235%
Returns for 5 years84.25140.3160%
Returns for 10 years274.47854.3932%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NDEKF25.702.31
+9.86%
Nitto Denko Corp.
MEPDF15.90N/A
N/A
Medipal Holdings Corp.
POSC1.45N/A
N/A
Positron Corp.
TRUHF0.14N/A
N/A
Truly International Holdings Ltd.
ADTI1.50N/A
N/A
Adapti, Inc.